A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients

Project: Other project

Project Details

StatusFinished
Effective start/end date8/12/166/30/17